Oxford BioDynamics Plc (LON:OBD – Get Free Report)’s share price rose 14.1% on Wednesday . The company traded as high as GBX 1.44 ($0.02) and last traded at GBX 1.31 ($0.02). Approximately 9,213,926 shares traded hands during trading, an increase of 665% from the average daily volume of 1,204,177 shares. The stock had previously closed at GBX 1.15 ($0.02).
Analyst Ratings Changes
Separately, Shore Capital reissued a “house stock” rating on shares of Oxford BioDynamics in a report on Tuesday, June 18th.
Check Out Our Latest Stock Report on Oxford BioDynamics
Oxford BioDynamics Stock Up 6.1 %
About Oxford BioDynamics
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.
Featured Stories
- Five stocks we like better than Oxford BioDynamics
- Top Stocks Investing in 5G Technology
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- Financial Services Stocks Investing
- AMD Gains Momentum With AI: Can It Beat Expectations?
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.